D. E. Shaw & Co »

Enliven Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.6M 194k 39.20

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
BlackRock
Polar Capital Holdings
Commodore Capital
Vestal Point Capital
Vanguard Group
Citadel Advisors
Fairmount Funds Management
VR Adviser
Novo A/S
Geode Capital Management
State Street Corporation
Logos Global Management
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics